🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
Hepatitis C is a common and potentially serious disease. However, there are...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07098481
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
The purpose of the study is to establish the proportion of patients on lipi...
Status
Completed
Location
Research Site
Start Date
2010-10
Trial ID
NCT01221584
This study is a first-in-human (FIH) study which is required to understand ...
Status
Completed
Location
National Cancer Center
Start Date
2019-08-09
Trial ID
NCT04014257
Treatments Being Tested
Primary Objective: To evaluate the efficacy of sarilumab at Week 16 in par...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2013-10
Trial ID
NCT01900431
Treatments Being Tested
The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY...
Status
Completed
Location
ARH Medical Mall
Start Date
2019-09-23
Trial ID
NCT03949764
Treatments Being Tested
The aim of this multi-part Phase 1 study is to evaluate the drug-drug inter...
Status
Completed
Location
Dr. Vince Clinical Research
Start Date
2025-05-13
Trial ID
NCT06945276
Treatments Being Tested
This study is a prospective, multi-cohort, single-centre, phase II clinical...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06055166
By 2030, pancreatic adenocarcinoma could become the second leading cause of...
Status
Recruiting
Location
Julie PERINEL
Start Date
2026-03-18
Trial ID
NCT07144917
Treatments Being Tested